全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

MiR-26a/b在AngⅡ导致的高血压血管重塑中的作用
Role of miR-26a/b in AngⅡ-induced hypertensive vascular remodeling

DOI: 10.7652/jdyxb201705005

Keywords: 高血压,血管重塑,microRNA,miRNA-26a/b,细胞外基质
hypertension
,vascular remodeling,microRNA,miRNA-26a/b,extracellular matrix

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要:目的 检测小鼠主动脉和血清中miR-26a/b的表达水平的变化,探讨miR-26a/b在高血压血管重塑中的作用。方法 将C576L/BJ雄性小鼠随机分为AngⅡ组和对照组。在小鼠背部皮下植入微渗透泵,持续泵入AngⅡ[2.0mg/(kg?d)]建立小鼠高血压血管重塑模型。对照组泵入生理盐水。分别于干预前和干预后的第3、5、7、10、14天进行血压测定。2周后处死小鼠,留取血清及主动脉组织,用RT-PCR测定miR-26a/b的表达水平。HE、Masson染色以及免疫组化观察血管形态学的变化、纤维化程度以及蛋白表达情况。结果 干预后,AngⅡ组的收缩压明显高于对照组(P<0.05),AngⅡ组的舒张压也明显高于对照组(P<0.05);主动脉HE染色显示AngⅡ组血管管壁较对照组明显增厚;Masson三色染色显示AngⅡ组主动脉中层有较多蓝色的胶原纤维沉积,对照组主动脉中层未见明显的胶原纤维沉积;RT-PCR显示AngⅡ组小鼠外周血血清和主动脉中miRNA-26a/b的表达量低于对照组(P<0.05);免疫组化显示泵入AngⅡ后,CTGF、collagenⅠ、collagenⅢ的表达水平升高(P<0.05)。结论 miR-26a/b、CTGF、collagenⅠ、collagenⅢ 都可能参与AngⅡ引起的高血压血管重塑,miR-26a/b在一定程度上可能成为高血压血管重塑的新的治疗靶点。
ABSTRACT: Objective To detect the expression of miR-26a/b in the aorta and serum of mice so as to explore the role of miR-26a/b in vascular remodeling of hypertension. Methods C576L/BJ male mice were randomly divided into AngⅡ group and control group. Mini-osmotic pump was implanted subcutaneously into the back of mice, and the model of blood vessel remodeling in mice was established by continuous infusion of AngⅡ(2.0mg/kg?d). The mice in control group were injected with saline. Blood pressure was taken before the intervention and at 3, 5, 7, 10 and 14 days after the intervention. After 2 weeks, the mice were killed, the serum and aorta tissues were collected, and the expression of miR-26a/b was determined by RT-PCR. HE staining, Masson staining and immunohistochemistry were performed to observe changes in vascular morphology, fibrosis and protein expression. Results After the intervention, systolic blood pressure and diastolic blood pressure were significantly higher in AngⅡ group than in control group (P<0.05). HE staining showed that the vessel wall of AngⅡ group was thicker than that of control group. Masson staining showed more blue collagen deposition in the middle of aorta in AngⅡ group but no obvious collagen deposition in control group. RT-PCR showed that the expression of miRNA-26a/b in the serum and aorta of AngⅡ group was significantly lower than in control group (P<0.05). Immunohistochemistry indicated that the expressions of CTGF, collagen Ⅰ and collagen Ⅲ all increased after AngⅡ infusion (P<0.05). Conclusion MiR-26a/b, CTGF, collagen Ⅰ and collagen Ⅲ may be involved in AngⅡ-induced vascular remodeling in hypertension. MiR-26a/b may be a new therapeutic target of vascular remodeling in hypertension

References

[1]  刘力生. 中国高血压防治指南2010[J]. 中华高血压杂志, 2011,19(8):701-703.
[2]  WEI Y, SCHOBER A,WEBER C. Pathogenic arterial remodeling: The good and bad in microRNAs[J]. Am J Physiol Heart Circ Physiol, 2013, 304(8):1050-1059.
[3]  LIU J, HUANG Y, CHEN S, et al. Role of endogenous sulfur dioxidein regulating vascular structural remodeling in hypertension[J]. Oxid Med Cell Longev, 2016, 2016:1-8.
[4]  WENZEL U, TURNER JE, KREBS C, et al. Immune mechanisms in arterial hypertension[J]. J Am Soc Nephrol, 2016, 27(3):677-686.
[5]  LING S, NANHWAN M, QIAN J, et al. Modulation of microRNAs in hypertension-induced arterial remodeling through the β1 and β3-adrenoreceptor pathways[J]. J Mol Cell Cardiol, 2013, 65:127-136.
[6]  ANTONIAK S, CARDENAS JC, BUCZEK LJ, et al. Pawlinski R Protease-activated receptor 1 contributes to angiotensin Ⅱ-induced cardiovascular remodeling and inflammation[J]. Cardiology, 2016, 136(4):258-268.
[7]  TAKAYANAGI T, KAWAI T, FORRESTER SJ, et al. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin Ⅱ[J]. Hypertension, 2015, 65(6):1349-1355.
[8]  KHUMAN MW, HARIKUMAR SK, SADAM A, et al. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats[J]. Toxicology, 2016, 374:29-41.
[9]  许康. 高血压血管重塑机制研究进展[J]. 实用医学杂志, 2010, 26(20):3827-3829.
[10]  崔瑞新,吕风华,岳 莹,等. microRNA-499靶控的PI3K/Akt通路在大鼠缺血-再灌注心肌损伤中的作用[J]. 郑州大学学报(医学版), 2016, 51(6):740-743.
[11]  ONO K. microRNAs and cardiovascular remodeling[J]. Adv Exp Med Biol, 2015, 888:197-213.
[12]  ZHANG ZH, LI J, LIU BR, et al. MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target[J]. J Cardiovasc Pharmacol, 2013, 62(3):312-319.
[13]  LIU Y, WANG Z, XIAO W. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes[J]. Mol Med Rep, 2016, 14(3):2860-2866.
[14]  LU J, HE ML, WANG L, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2[J]. Cancer Res, 2011, 71(1):225-233.
[15]  LEEPER NJ, RAIESDANA A, KOJIMA Y, et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function[J]. J Cell Physiol, 2011, 226(4):1035-1043.
[16]  ZHANG J, HAN C, WU T. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin[J]. Gastroenterology, 2012, 143(1):246-256.
[17]  XU S, WANG T, YANG Z, et al. miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13[J]. Oncotarget, 2016, 7(29):45687-45701.
[18]  LIU LJ , YAO FJ , LU GH, et al. The role of the Rho/ROCK pathway in AngⅡ and TGF-β1-induced atrial remodeling[J]. PLoS One, 2016, 11(9):1-16.
[19]  KOGA K, YOKOI H, MORI K, et al. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy[J]. Diabetologia, 2015, 58(9):2169-2180.
[20]  SFERRA R, VETUSCHI A, POMPILI S, et al. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis[J]. Pathol Res Pract, 2017, 213(1):58-65.
[21]  CHATZIFRANGKESKOU M, LE DOUR C, WU W, et al. ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene[J]. Hum Mol Genet, 2016, 25(11):2220-2233.
[22]  JI J, YU L, YU Z, et al. Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma[J]. Int J Biol Sci, 2013, 9(3):303-312.
[23]  ZHANG B, JIANG J, YUE Z, et al. Store-operated Ca????2+?? entry (SOCE) contributes to angiotensin Ⅱ-induced cardiac fibrosis in cardiac fibroblasts[J]. J Pharmacol Sci, 2016, 132(3):171-180.
[24]  GAO F, WANG Y, LI S, et al. Inhibition of p38 mitogen-activated protein kinases attenuates renal interstitial fibrosis in a murine unilateral ureteral occlusion model[J]. Life Sci, 2016, 167:78-84.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133